Anuja Antony
Plastic and Reconstructive Surgery · Cary, NCNPI 1528228277
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $254,117 of the $326,062 with a category attached, or 77.9%. AbbVie accounts for 82.9% of it on its own, with 17 other manufacturers making up the rest. Among plastic and reconstructive surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 334 payments — averaging $976.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$270K
- Stryker$26K
- Davol Inc.$25K
- Merz North America, Inc.$3K
- Biom'up France SAS$1K
- Sientra, Inc.$186
- plus $1K from 12 others
Across 5 payments — averaging $9670.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$48K
What the payments were for
- Consulting fees$254,11778%
- Speaking & faculty fees$37,01311%
- Travel & lodging$24,4107%
- Food & beverage$10,4523%
- Entertainment$700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 261 | $270,234 |
| Stryker | 17 | $25,966 |
| Davol Inc. | 22 | $24,874 |
| Merz North America, Inc. | 14 | $2,705 |
| Biom'up France SAS | 1 | $1,000 |
| Sientra, Inc. | 1 | $186 |
| Acera Surgical, Inc. | 1 | $134 |
| RTI Surgical, Inc | 1 | $126 |
| Johnson & Johnson | 2 | $126 |
| BD | 2 | $118 |
| Galderma Laboratories, L.p. | 2 | $106 |
| Revance Therapeutics, Inc. | 3 | $103 |
| Kls-martin L.p. | 1 | $102 |
| Medtronic | 1 | $91 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $70 |
| Motiva USA, LLC | 2 | $58 |
| TELA Bio, Inc. | 1 | $41 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE SALINE-FILLED BREAST IMPLANTS$128,224
- REVOLVE$56,145
- NATRELLE$48,069
- ALLODERM$17,012
- 1688$13,768
- STRATTICE$12,204
- SPY TECHNOLOGY$8,647
- ARTIA RECONSTRUCTIVE TISSUE MATRIX$4,200
- BOTOX$3,823
- SPY-PHI SYSTEM$3,281
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$1,050
- HemoBlast Bellows$1,000
- BOTOX COSMETIC$525
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$186
- Phasix Mesh$138
- Restrata Wound Matrix$134
- CORTIVA ALLOGRAFT DERMIS$126
- XEOMIN$111
How this compares
$326,062 in reported general payments places this provider in the 95th percentile of 55 plastic and reconstructive surgery providers in North Carolina.
See all plastic and reconstructive surgery providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 18 | $146 |
| Ondansetron OdtOndansetron | 12 | $67 |
| Oxycodone Hcl | 15 | $36 |
| Gabapentin | 14 | $10 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Cary
- Brian CoanCary$41K
- Cynthia GreggCary$6K
- Kimberly JonesCary$1K
- Donald HannaCary$421
- Jeffrey MarcusDurham$3.3M
- Peter ArnoldGreensboro$206K
- Joseph HunstadCharlotte$144K
- Charles HultmanRaleigh$70K
- Charles KaysWilmington$69K
- Benjamin WoodRaleigh$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.